B-Cure Laser Global
B-Cure Laser Global is an Israeli medical device company that develops and markets handheld low-level laser therapy devices for home and clinical treatment of acute and chronic pain, orthopedic conditions, sports injuries, and wounds, selling primarily direct-to-consumer and through authorized distributors worldwide.
- Company typePrivate
- Founded2009
- HeadquartersLondon, United Kingdom
- Headcount—
- GTM typeB2C
- OfferingHardware or Manufacturing
What B-Cure Laser Global does
B-Cure Laser Global, legally Erika B-Cure Laser Ltd., is a privately held Israeli medical device company founded in 2009 that develops and markets low-level laser therapy (LLLT) devices for the treatment of acute and chronic pain, orthopedic conditions, sports injuries, and wounds. The company's core technology operates at an 808nM wavelength, positioned as the optimized point within the clinically validated 660–905nM band, and uses low-level laser beams that penetrate skin without heat, damage, or pain to trigger biostimulation (photochemical reactions that increase cellular ATP production, enhance blood flow, release endorphins, and promote tissue regeneration). A patented device architecture delivers full-power soft laser in a portable, palm-sized, rechargeable form factor suitable for both home and clinical use.
The product portfolio consists of two main devices — the B-Cure Laser Pro and the B-Cure Laser Classic — both certified as Class 2a medical devices with CE 0197 marking, Health Canada clearance, and ANVISA approval, supplemented by an Adjustable Stand accessory for hands-free use. The company generates revenue primarily through one-time hardware sales priced at approximately ₪2,533 per device, with no disclosed recurring revenue stream.
B-Cure sells predominantly through direct-to-consumer e-commerce on bcurelaser.com and through authorized regional distributors, targeting three end segments: individual consumers with chronic or acute pain conditions, healthcare professionals (physiotherapists, chiropractors, pain specialists, orthopedic surgeons, rehabilitation specialists), and professional athletes and sports organizations. The company claims more than 350,000 devices sold worldwide across the UK, Canada, France, Brazil, the US, and other markets, supported by endorsements from clinicians, Olympic and Paralympic athletes, and a portfolio of clinical trials conducted with Sapienza University Rome, Hadassah Hospital, the University of Parma, and Beneficência of São Paulo Hospital. The company is bootstrapped with no disclosed institutional funding and operates under ISO 9001 quality certification.
B-Cure Laser Global firmographics
Firmographics- Name
- B-Cure Laser Global
- Legal name
- Erika B-Cure Laser Ltd.
- Website
- https://bcurelaser.com
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Short description
- B-Cure Laser Global is an Israeli medical device company that develops and markets handheld low-level laser therapy devices for home and clinical treatment of acute and chronic pain, orthopedic conditions, sports injuries, and wounds, selling primarily direct-to-consumer and through authorized distributors worldwide.
- Ownership category
- akta.pro rank
B-Cure Laser Global industry classification
Industry- Product category
- Medical Devices (Therapeutic Laser / Pain Management)
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser) (HLAHADAC)
- akta.pro secondary industries
- Laser & Energy-Based Dermatology (HLAKACAF), Wound Care & Ulcer Management (HLAKACAN)
Keywords
Where B-Cure Laser Global is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices2 records
Markets served
B-Cure Laser Global business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Marketing or Sales, Operations, Personnel, Technology or R&D
Revenue model
- Device Sales: One-time hardware sales of B-Cure Laser Pro and B-Cure Laser Classic devices. Primary revenue stream from direct-to-consumer e-commerce sales of medical laser therapy devices.
- Accessory Sales: Sales of complementary accessories such as the Adjustable Stand (₪240.00), providing additional revenue from existing customer base.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | B-Cure Laser Pro - Professional device for pain management and healing |
| One time/ perpetual license | Pay-as-you-go | B-Cure Laser Classic - Standard device for home use |
| Unit Pricing | Pay-as-you-go | Adjustable Stand - Accessory for hands-free use |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels6 records
B-Cure Laser Global product offering
Product offeringCore offering
B-Cure Laser Global develops, manufactures, and sells handheld Low-Level Laser Therapy (LLLT) medical devices — the B-Cure Laser Pro and B-Cure Laser Classic — for home and clinical treatment of acute and chronic pain, orthopaedic conditions, sports injuries, and wounds. The devices operate at an 808nM wavelength, are Class 2a medical devices with CE 0197, Health Canada, and ANVISA approvals, and are sold direct-to-consumer via bcurelaser.com and through authorized distributors globally.
Product overview
B-Cure Laser Global offers a focused portfolio of low-level laser therapy (LLLT) medical devices for home and clinical use. The product line consists of two main devices — B-Cure Laser Pro and B-Cure Laser Classic — both based on the same proprietary LLLT technology platform operating at 808nM wavelength. Both devices are Class 2a medical devices with CE marking, Health Canada clearance, and ANVISA approval. The portfolio is complemented by an Adjustable Stand accessory that enables hands-free operation. The company positions these devices as solutions for treating acute and chronic pain, orthopaedic conditions, sports injuries, and wounds.
Differentiator
Problem solved
Functional benefit
Brands
- B-Cure Laser Pro: Professional-grade low-level laser therapy device for treating pain, arthritis, and wounds.
- B-Cure Laser Classic
Products and services
- B-Cure Laser Pro Handheld Low-Level Laser Therapy (LLLT) medical device for treating acute and chronic pain, orthopaedic conditions, sports injuries, and wounds; Class 2a medical device with CE 0197 marking, Health Canada clearance, and ANVISA approval; designed for home and clinical use by individual consumers and healthcare practitioners.
- B-Cure Laser Classic Handheld Low-Level Laser Therapy (LLLT) medical device for treating acute and chronic pain, orthopaedic conditions, sports injuries, and wounds; Class 2a medical device with CE 0197 marking, Health Canada clearance, and ANVISA approval; positioned for personal home use.
- Adjustable Stand Adjustable stand accessory for hands-free use of B-Cure Laser devices; can be stabilised on any surface or attached to furniture or body parts during treatment; sold as a standalone accessory to B-Cure Laser device owners.
Quantifiable outcome
- Over 350,000 devices sold worldwide
- +4 more outcomes
Companies that use B-Cure Laser Global
Customer profileNamed customers17 records
Segments3 records
Ideal customer profiles3 records
B-Cure Laser Global technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
B-Cure Laser Global partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Ningjing International Co., Ltd. (甯靖國際有限公司)coreAuthorized distributor of B-Cure Laser products. Contact: [email protected], https://ningjingcare.com/. Extends market reach in designated distribution territories.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
B-Cure Laser Global competitors and assessment
Company assessmentBroad incumbents
- DJO Global (Enovis): Large orthopedic and rehabilitation device company (formerly Chattanooga Group) offering a broad portfolio including electrotherapy, ultrasound, and laser therapy products for clinical pain management. Broader incumbent that competes indirectly with B-Cure through professional distribution channels.
- BTL Group: Global medical device manufacturer offering non-invasive solutions for physiotherapy, pain management, and aesthetics, including laser and shockwave therapy. Broader incumbent competing for the same physiotherapy and pain management customer wallet share as B-Cure.
Direct peers
- Mectronic Medicale: Italian manufacturer of high-power LLLT and Hilterapia laser therapy devices for orthopedics, sports medicine, and rehabilitation. Comparable European competitor with overlapping CE-marked product positioning and professional-channel focus.
- K-Laser USA: US distributor of K-Laser brand high-power LLLT devices for human and veterinary applications. Competes directly with B-Cure in the professional/clinical channel for pain management, sports injury, and rehabilitation use cases.
- Erchonia Corporation: US-based manufacturer of low-level laser therapy devices for pain management, wound healing, and musculoskeletal conditions. Closest direct competitor to B-Cure with overlapping 635-635nm red and near-infrared wavelengths and FDA-cleared indications.
- LiteCure: US-based manufacturer of LLLT (cold laser) devices including the LightForce and Companion brands for veterinary, sports medicine, and rehabilitation markets. Direct competitor with overlapping professional-channel focus and similar class-IV/IIIb laser platforms.
- Aspen Laser Systems: US-based LLLT device manufacturer focused on chiropractors, physical therapists, and pain management specialists. Directly comparable product offering in pain and inflammation reduction, with overlapping professional endorsement-driven GTM.
- THOR Photomedicine: UK-based developer of LLLT/photobiomodulation devices for clinicians, treating pain, inflammation, and tissue repair. Operates in overlapping home and clinical-use segments with B-Cure and competes for the same professional recommendation channel.
- Multi Radiance Medical: US manufacturer of FDA-cleared LLLT and pulsed electromagnetic field (PEMF) combination devices for pain management and rehabilitation. Direct competitor in the professional/clinical LLLT segment targeting chiropractors, physical therapists, and sports medicine practices.
Regional players
- BioLight Life Sciences: Israeli-based ophthalmic and life sciences investment platform. Compares as a same-domicil (Israel) life sciences company but operates in fundamentally different therapeutic categories (ophthalmology, drug delivery), making the connection weak and indirect.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
B-Cure Laser Global social profiles
Digital presenceB-Cure Laser Global compliance and trust
Trust signalCompliance4 records
B-Cure Laser Global financial estimates
Financial estimateRevenue estimate
Valuation estimate
B-Cure Laser Global leadership team
Management profileNumber of profiles
B-Cure Laser Global funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
B-Cure Laser Global M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about B-Cure Laser Global
What does B-Cure Laser Global do?
B-Cure Laser Global develops, manufactures, and sells handheld Low-Level Laser Therapy (LLLT) medical devices — the B-Cure Laser Pro and B-Cure Laser Classic — for home and clinical treatment of acute and chronic pain, orthopaedic conditions, sports injuries, and wounds. The devices operate at an 808nM wavelength, are Class 2a medical devices with CE 0197, Health Canada, and ANVISA approvals, and are sold direct-to-consumer via bcurelaser.com and through authorized distributors globally.
Is B-Cure Laser Global a public or private company?
B-Cure Laser Global is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was B-Cure Laser Global founded?
B-Cure Laser Global was founded in 2009.
Where is B-Cure Laser Global based?
B-Cure Laser Global is headquartered in London, United Kingdom, in the Europe region.
How does B-Cure Laser Global make money?
Two revenue lines are on record. Device Sales are the primary driver. The others are accessory Sales.
Who are B-Cure Laser Global's main competitors?
Broad incumbents on record are DJO Global (Enovis) and BTL Group. Direct peers are Mectronic Medicale, K-Laser USA, Erchonia Corporation, LiteCure, Aspen Laser Systems, THOR Photomedicine and Multi Radiance Medical. BioLight Life Sciences is listed as a regional player.
Does B-Cure Laser Global have an API?
No public API is recorded for B-Cure Laser Global.
What industry is B-Cure Laser Global in?
B-Cure Laser Global's product category is Medical Devices (Therapeutic Laser / Pain Management). Its primary akta.pro industry code is HLAHADAC, Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser), with a secondary code of HLAKACAF, Laser & Energy-Based Dermatology. Its NAICS code is 334510 and its SIC code is 3845.